Acquired inflammatory demyelinating neuropathies

Physical Medicine and Rehabilitation Clinics of North America

Volumn 12, Issue 2, 2001, Pages 321-334

  Ensrud, E R ^a   Krivickas, L S ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DISEASE COURSE; DYSAUTONOMIA; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR NEUROPATHY; PATHOGENESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSORY NEUROPATHY; TREATMENT PLANNING;

EID: 0035039509     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1047-9651(18)30072-x     Document Type: Review

References (43)

1. The epidemiology of Guillain-Barré syndrome
2. The inflammatory lesion in idiopathic polyneuritis: Its role in pathogenesis
3. Assessment of current diagnostic criteria for Guillain-Barré syndrome
4. Disorders of peripheral nerves
5. Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis
6. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle
7. Serum anti-GQ1b IgG antibody is associated with ophthalmophegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies
8. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
9. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
10. A plasma exchange versus immunoglobulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy
11. Chronic inflammatory demyelinating polyradiculoneuropathy
12. An acute axonal form of Guillain-Barré polyneuropathy
13. Quantitative assessment of cardiovascular autonomic function in Guillain Barré syndrome
14. Appropriate number of plasma exchanges in Guillain-Barré syndrome
15. Chronic inflammatory demyelinating polyneuropathy: Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy
16. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy
17. Pathology of the motor-sensory axonal Guillain-Barré syndrome
18. Sur un syndrome de radiculonebrite du liquide cephalorachidian sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux
19. Double-blind trial of intravenous methylprednisolone in Guillain Barré syndrome
20. Guillain-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
21. Subacute idiopathic demyelinating polyradiculoneuropathy
22. Campylobacter jejuni infection and treatment for Guillain-Barré syndrome
23. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome
24. Distal acquired demyelinating symmetric neuropathy
25. The effect of a high resistance exercise program in slowly progressive neuromuscular disease
26. Guillain-Barré syndrome after exogenous gangliosides in Italy
27. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines
28. The autonomic neuropathies
29. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
30. Plasmapheresis and Guillain-Barré syndrome: Analysis of prognostic factors and the effect of plasmapheresis
31. Guillain-Barré syndrome: Rehabilitation outcome and recent developments
32. Prediction of outcome in Guillain-Barré syndrome patients admitted to rehabilitation
33. Pain in Guillain-Barré syndrome
34. Serum antibodies to heparin sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies
35. Autoantibodies associated with peripheral neuropathy
36. Campylobacter jejuni infection and Guillain-Barré syndrome
37. The spectrum of chronic inflammatory demyelinating polyneuropathy
38. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome
39. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults
40. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II Long-term follow-up with comparison to adults
41. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome
42. IgG receptor alleles determine susceptibility and severity of Guillain-Barré syndrome
43. Development of weakness in patients with chronic demyelinating polyneuropathy and only sensory symptoms at presentation: A long-term follow-up study